摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-5,5,5-trifluoropentanoic acid | 2365-80-2

中文名称
——
中文别名
——
英文名称
2-amino-5,5,5-trifluoropentanoic acid
英文别名
2-azaniumyl-5,5,5-trifluoropentanoate
2-amino-5,5,5-trifluoropentanoic acid化学式
CAS
2365-80-2
化学式
C5H8F3NO2
mdl
MFCD00190648
分子量
171.119
InChiKey
KTZZIDWVKLDWBF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    254-256 °C
  • 沸点:
    206.7±40.0 °C(Predicted)
  • 密度:
    1.356±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.5
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    6

SDS

SDS:422ba72d62592ac0d9428a74839dcdd6
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
    申请人:Wyeth
    公开号:US20040198778A1
    公开(公告)日:2004-10-07
    Compounds of Formula (I), 1 are provided where T is CHO, CON, or C(OH)R 1 R 2 ; R 1 and R 2 are hydrogen, optionally substituted lower alkyl, CF 3 , optionally substituted alkenyl, or optionally substituted alkynyl; R 3 is hydrogen or optionally substituted lower alkyl; R 4 is (CF 3 ) n alkyl, (CF 3 ) n (substitutedalkyl), (CF 3 ) n alkylphenyl, (CF 3 ) n alkyl(substitutedphenyl), or (F) n cycloalkyl; n=1-3; R 5 is hydrogen, halogen, CF 3 , diene fused to Y when Y═C, or substituted diene fused to Y when Y═C; W, Y and Z are C, CR 6 or N where at least one of W, Y or Z are C; R 6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO 2 , or NR 7 ; R 7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R 8 is lower alkyl, CF 3 , or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.
    提供了具有式(I)的化合物,其中T为CHO、CON或C(OH)R1R2;R1和R2为、可选择取代的较低烷基、CF3、可选择取代的烃或可选择取代的炔烃;R3为或可选择取代的较低烷基;R4为( )n烷基、( )n(取代烷基)、( )n烷基基、( )n烷基(取代基)或(F)n环烷基;n=1-3;R5为、卤素、 、与Y融合的双烯烃(当Y为C时)、或与Y融合的取代双烯烃(当Y为C时);W、Y和Z为C、CR6或N,其中至少有一个为C;R6为、卤素或可选择取代的较低烷基;X为O、S、SO2或NR7;R7为、可选择取代的较低烷基、可选择取代的苄基或可选择取代的基;R8为较低烷基、 或可选择取代的基。还描述了制备和使用这些化合物来抑制β淀粉样蛋白的产生,以及治疗阿尔茨海默病和唐氏综合征的方法。
  • Fluorine containing amino acids and their derivatives. 7. Synthesis and antitumor activity of α- and γ-substituted methotrexate analogs
    作者:Tadahiko Tsushima、Kenji Kawada、Shoichi Ishihara、Naomi Uchida、Osamu Shiratori、Junko Higaki、Masaharu Hirata
    DOI:10.1016/s0040-4020(01)86044-0
    日期:1988.1
    afforded a number of fluorine containing α amino acids such as β-fluorinated-alanines, 2-amino-n,n,n-trifluoroalkanoic acids, and fluorinated glutamic acids as well as other γ-heteroatom substituted glutamic acids. Here, an efficient enzymatic optical resolution using hog kidney acylase was conducted to obtain both optical isomers of 2-amino-n,n,n-trifluoroalkanoic acids. In addition, a novel sulfoxide
    α-取代的丙二酸的三种类型的反应,二甲基化,与n,n,n-三氟烷磺酸的烷基化以及与2-取代的丙烯酸的Michael加成反应,可方便地得到许多含的α氨基酸,​​例如β-代丙酸。 ,2-基-n,n,n-三链烷酸和化谷酸以及其他γ-杂原子取代的谷酸。在此,进行了使用猪肾酰基转移酶的有效酶促光学拆分,以获得2-基-n,n,n-三链烷酸的两种旋光异构体。另外,在α-二甲基-α-亚磺酰丙二酸二乙酯的碱催化反应中观察到了新的亚砜重排。最后,获得的α-和γ-取代的谷酸用于抗肿瘤药甲氨蝶呤化学修饰,以显示出显着的构效关系。特别是,取代对观察到体内抗肿瘤活性。
  • Synthesis and physical chemical properties of 2-amino-4-(trifluoromethoxy)butanoic acid – a CF<sub>3</sub>O-containing analogue of natural lipophilic amino acids
    作者:Ivan S. Kondratov、Ivan G. Logvinenko、Nataliya A. Tolmachova、Roman N. Morev、Maria A. Kliachyna、Florian Clausen、Constantin G. Daniliuc、Günter Haufe
    DOI:10.1039/c6ob02436j
    日期:——
    2-Amino-2-(trifluoromethoxy)butanoic acid (O-trifluoromethyl homoserine) was synthesized as a racemate and in both enantiomeric forms. The measured pKa and log D values establish the compound as a promising analogue of natural aliphatic amino acids.
    合成了外消旋体和两种对映体形式的2-基-2-(三基)丁酸(O-三甲基丝氨酸)。测得的p K a和log  D值确定该化合物为天然脂族氨基酸的有前途的类似物。
  • The Synthesis of Tenuazonic and Congeneric Tetramic Acids
    作者:Stanton A. Harris、Linda V. Fisher、Karl Folkers
    DOI:10.1021/jm00328a014
    日期:1965.7
  • Inhibition of the mammalian .beta.-lactamase renal dipeptidase (dehydropeptidase-I) by Z-2-(acylamino)-3-substituted-propenoic acids
    作者:Donald W. Graham、Wallace T. Ashton、Louis Barash、Jeannette E. Brown、Ronald D. Brown、Laura F. Canning、Anna Chen、James P. Springer、Edward F. Rogers
    DOI:10.1021/jm00389a018
    日期:1987.6
    The title enzyme deactivates the potent carbapenem antibiotic imipenem in the kidney, producing low antibiotic levels in the urinary tract. A series of (Z)-2-(acylamino)-3-substituted-propenoic acids (3) are specific, competitive inhibitors of the enzyme capable of increasing the urinary concentration of imipenem in vivo. Many of the compounds were prepared in one step from an alpha-keto acid and a primary amide. The optimum R2 groups are 2,2-dimethyl, -dichloro, and -dibromocyclopropyl. With R2 = 2,2-dimethylcyclopropyl (DMCP), a wide variety of R3 groups including alkyl, oxa- and thiaalkyl, and alkyl groups containing acidic, basic, and neutral substituents give effective inhibitors with Ki values of 0.02-1 microM and a range of pharmacokinetic properties. By resolution of enantiomers and X-ray crystallography, the enzyme-inhibitory activity of the DMCP group was found to reside with the 1S isomer. The cysteinyl compound 176 (cilastatin, MK-0791) has the desired pharmacological properties and has been chosen for combination with imipenem.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸